The Drug Combination Competition

... marketed FDCs and other combination regimens spanning multiple therapeutic areas, including infectious disease (HIV/AIDS, Hepatitis C, bacterial infections); oncology; endocrine disorders (diabetes, lipids); cardiovascular disease (hypertension, ...

http://www.pharmexec.com/pharmexec/Strategy/The-Drug-Combination-Competition/ArticleStandard/Article/detail/822710?ref=25